Page last updated: 2024-08-23

amikacin and Vascular Injuries

amikacin has been researched along with Vascular Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, Y; Fang, F; Hong, W; Lakota, K; Sato, S; Sodin-Semrl, S; Taniguchi, T; Varga, J; Yamashita, T; Yoshizaki, A; Zhou, X	1

Other Studies

1 other study(ies) available for amikacin and Vascular Injuries

Article	Year
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. Scientific reports, 2018, 08-07, Volume: 8, Issue:1 Topics: Administration, Oral; Animals; Bleomycin; Disease Models, Animal; Female; Fibrosis; Humans; Inflammation; Mice, Inbred C57BL; Piperidines; Receptors, Adiponectin; Scleroderma, Systemic; Signal Transduction; Skin; Vascular System Injuries	2018

Article

Year

An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.

Scientific reports, 2018, 08-07, Volume: 8, Issue:1

Topics: Administration, Oral; Animals; Bleomycin; Disease Models, Animal; Female; Fibrosis; Humans; Inflammation; Mice, Inbred C57BL; Piperidines; Receptors, Adiponectin; Scleroderma, Systemic; Signal Transduction; Skin; Vascular System Injuries

2018